drug development
Drug development contracts: can lessons be learned from healthcare delivery?
March 16, 2015Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing CCG, CRO, Les Rose, NHS, drug development, trials
There is a very good question to ask at the beginning of every project: “What does success look like?” If …
Alzheimer’s drug development ‘must speed up’
November 7, 2013Research and Development, Sales and Marketing Alzheimer's, CEO, drug development
Alzheimer’s drugs cost three times the industry average to produce, according to a new draft report – and the way …
New venture a ‘game-changer’ for pharma
October 25, 2011Research and Development Sir Christopher Evans, drug development
Sir Christopher Evans is looking to create a new venture that aims to improve on the drug development productivity of …
Innovation – is it science or art?
June 14, 2011Manufacturing and Production, Research and Development creativity, drug development, innovation
In recent times new drug development has shown a substantial decline in the number of approved drugs for human use. …
The utility of next generation sequencing in drug development
November 3, 2010Research and Development Dr Cheng Eng Ang, Illumina, Source BioScience, drug development, genomics, human genome, next generation sequencing
Drug development studies are extremely expensive, costing many millions of pounds and taking up to 12 years to bring a …
No sign of revival in R&D productivity
June 30, 2010Research and Development drug development, industry, research
New data on the performance of the pharmaceutical industry shows efforts to raise productivity have not yet made an impact. …
Real World Development: Increasing value for patients
June 30, 2010Research and Development Kinapse, drug development
The traditional drug development paradigm is protracted and costly, with many products failing to deliver commercial or clinical success.We propose …
Caution: you are entering phase III
December 8, 2008Research and Development clinical trials, drug development, phase III
Patient: "I've just gone into phase III! What are my chances of coming through alive?" Doctor: "Well the prognosis is …
The Pharmafocus Interview: John Patterson
December 19, 2007Research and Development, Sales and Marketing AstraZeneca, drug development, industry relations
John Patterson is an AstraZeneca man through-and-through, having spent nearly all his working life at the company. But over the …
Safety first
December 10, 2007Research and Development, Sales and Marketing clinical trials, drug development, drug safety
There is a tide of change in drug safety within the pharmaceutical industry. Internal and external forces are pushing drug …
Time is money in R&D
July 16, 2007Research and Development clincial trials, drug development, productivity
There is a much-quoted statistic, which has become so hackneyed that it's largely ignored these days, but while you are …
HIV market: collaborative combinations
March 26, 2007Research and Development, Sales and Marketing HIV, drug development, marketing
Two new HIV drugs, from Tibotec and Gilead, have been shown to be viable late-stage pipeline candidates. However, both TMC278 …
Gene therapy: the tailor-made treatment
June 28, 2006Research and Development drug development, gene therapy
At the risk of boring my audience, I really can't help beginning with yet another attack of nostalgia ,or rather …
EDC – turning the corner?
October 22, 2003Research and Development EDC, drug development, electronic data capture, technology
Electronic Data Capture is a way of eliminating paper in the data collection process by capturing the data directly into …
Waiting for the upturn
October 15, 2003Research and Development drug development, pipelines
Estimates vary considerably, but many analysts put the current cost of bringing a drug to market at around $800 million, …
Latest content
Global coalition calls for stronger government action on COPD
Global health researchers call for more equitable partnerships
Liverpool launches £20m lab for infectious disease drug discovery
Circle Health Group expands into UK laboratory operations
